News and Information-Learn About Hepatitis, Liver Cirrhosis, and Others
A Member of the Healthscout Network
 Printer Friendly  Send to a Friend

Pig Stem Cells Created

Organ transplants and other revolutionary uses predicted for humans, study says

WEDNESDAY, June 3 (HealthDay News) -- Using cells from pig ears and bone marrow, researchers in China generated a type of stem cell capable of developing into any type of cell in the body.

This is the first time researchers have created pluripotent stem cells using cells from a hooved animal that weren't derived from sperm or eggs. Like embryonic stem cells, pluripotent stem cells can differentiate into other types of cells.

Advertisement
Related Stories
 border=
Lung Transplant Outcome Might Hinge on Hospital Location
Hepatitis A Vaccine Pays Off for Kids: Study
Eye Condition May Alter Corneal Transplant Results
Related Videos
 border=
Blood Cleaner
High Tech Liver Surgery
Living Longer With Liver Cancer
Related Slides
 border=
Hepatitis
Liver Cirrhosis
Liver Transplant
Related Encyclopedia
 border=
Arteriohepatic Dysplasia
Fatty Liver
Hemochromatosis


The researchers hope their discovery will move scientists closer to genetically engineering pigs for organ transplants for humans and developing pigs that are resistant to diseases such as swine flu.

The study findings were published online June 3 in the Journal of Molecular Cell Biology.

"The pig species is significantly similar to humans in its form and function, and the organ dimensions are largely similar to human organs," lead study author Lei Xiao, who heads the stem-cell lab at the Shanghai Institute of Biochemistry and Cell Biology, said in a news release from the journal. "We could use embryonic stem cells or induced stem cells to modify the immune-related genes in the pig to make the pig organ compatible to the human immune system. Then we could use these pigs as organ donors to provide organs for patients that won't trigger an adverse reaction from the patient's own immune system."

Pig pluripotent stem-cell lines could also be used to help study human genetic diseases, Xiao noted.

"Many human diseases, such as diabetes, are caused by a disorder of gene expression," Xiao said in the news release. "We could modify the pig gene in the stem cells and generate pigs carrying the same gene disorder so that they would have a similar syndrome to that seen in human patients. Then it would be possible to use the pig model to develop therapies to treat the disease."

To induce the pluripotent cells, researchers used a virus to introduce transcription factors, which reprogram cells, to cells taken from a pig's ear and bone marrow. After the introduction of transcription factors, the cells developed in the lab into colonies of embryonic-like stem cells.

Further tests confirmed the cells were capable of differentiating into the cell types that make up the three layers in an embryo -- endoderm, mesoderm and ectoderm -- a characteristic of all embryonic stem cells.

The discovery will make it easier for researchers to develop embryonic stem cells from embryos of pigs and other hooved animals, known as ungulates, according to the study.

Although treatments in humans are several years away or more, Xiao said his next research will be using the induced pluripotent cells to generate gene-modified pigs that could provide organs for patients or aid in disease resistance.

The induced pluripotent cells could either be used to transfer an additional bit of genetic material (such as a piece of human DNA) into the pig's genome or to prevent a particular gene from functioning.

"This research is very exciting because it represents the first rigorous demonstration of the establishment of pluripotent stem cell in ungulate species, which will open up interesting opportunities for creating precise, gene-modified animals for research, therapeutic and agricultural purposes," said Dangsheng Li, the journal's editor-in-chief, in the news release.

More information

For more on stem cells, visit the U.S. National Institutes of Health's resource for stem cell research.

-- Jennifer Thomas

SOURCE: Journal of Molecular Cell Biology, news release, June 2, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 6/3/2009



Disclaimer: The information provided on this website is for educational purposes only and does not serve as a replacement for care provided by your own personal health care team. This website does not render or provide medical advice, and no individual should make any medical decisions or change their health behavior based on information provided here. All pertinent content provided on this website should be discussed with your personal physician to evaluate whether it has any relevance to or impact on your specific condition. Reliance on any information provided by this website is solely at your own risk.


Aug 1, 2010
Home
Search
Powered By HealthLine
Patient Guide
News
Health Videos
Health Encyclopedia
Health News Archive
Affiliate Information
HealthScout Network
Contact Us
Newsletters
Privacy Policy
Terms of Use

We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service  

To find more information on specific conditions, please visit our partner sites: